Last week, we announced that a stealth company would make its public debut at this afternoon’s (Tuesday, November 17) Healthcare Summit at the Broad Institute in Kendall Square. Now we can tell you that the company is Codiak BioSciences and the speaker, former Biogen research head Doug Williams, is its new CEO. (Williams has also been involved with other companies big and small on both coasts, including Immunex, ZymoGenetics, Amgen, and Seattle Genetics.)
Codiak, which is developing exosome-based drugs and diagnostics centered around technology from Houston’s MD Anderson Cancer Center, announced itself in the press this morning—with word that it has attracted an impressive $80 million in venture commitments.
The details of Codiak’s announcement are in Ben Fidler’s story today. But now is your chance to get a ticket to hear Williams lay out firsthand what Codiak is about. Tickets are available online until noon EST and you can also walk in, space permitting.
You can register and see the whole agenda to this event here. We have an all-star lineup—and it just got even stronger with Williams and Codiak. We hope to see you later today—Tuesday, November 17.
Author: Robert Buderi
Bob is Xconomy's founder and chairman. He is one of the country's foremost journalists covering business and technology. As a noted author and magazine editor, he is a sought-after commentator on innovation and global competitiveness. Before taking his most recent position as a research fellow in MIT's Center for International Studies, Bob served as Editor in Chief of MIT's Technology Review, then a 10-times-a-year publication with a circulation of 315,000. Bob led the magazine to numerous editorial and design awards and oversaw its expansion into three foreign editions, electronic newsletters, and highly successful conferences. As BusinessWeek's technology editor, he shared in the 1992 National Magazine Award for The Quality Imperative.
Bob is the author of four books about technology and innovation. Naval Innovation for the 21st Century (2013) is a post-Cold War account of the Office of Naval Research. Guanxi (2006) focuses on Microsoft's Beijing research lab as a metaphor for global competitiveness. Engines of Tomorrow (2000) describes the evolution of corporate research. The Invention That Changed the World (1996) covered a secret lab at MIT during WWII. Bob served on the Council on Competitiveness-sponsored National Innovation Initiative and is an advisor to the Draper Prize Nominating Committee. He has been a regular guest of CNBC's Strategy Session and has spoken about innovation at many venues, including the Business Council, Amazon, eBay, Google, IBM, and Microsoft.
View all posts by Robert Buderi
